ADP
57
2
RF
44
10
PWR
63
3
GD
42
4
BXP
39
5
GS
65
16
ESS
44
5
CME
59
3
HUM
25
4
DFS
64
4
NDAQ
46
2
KHC
11
2
JCI
44
7
NWSA
69
4
AIZ
61
5
KIM
58
2
EMC
30
-26
MKC
54
3
UPS
51
6
PCG
59
9
ADP
57
2
RF
44
10
PWR
63
3
GD
42
4
BXP
39
5
GS
65
16
ESS
44
5
CME
59
3
HUM
25
4
DFS
64
4
NDAQ
46
2
KHC
11
2
JCI
44
7
NWSA
69
4
AIZ
61
5
KIM
58
2
EMC
30
-26
MKC
54
3
UPS
51
6
PCG
59
9
Financhill
Back

Arbutus Biopharma Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
27

ABUS
Arbutus Biopharma

Last Price:
$3.20
Seasonality Move:
21.65%
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
$65.65
Seasonality Move:
5.39%
Sell
27
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.21. The Score for ABUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $65.69. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $65.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 33.79 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.35 - 3.65) Sell
Bollinger Bands (100): (3.53 - 4.11) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 48.8 Sell
Chaikin Money Flow: 1709604 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.56 - 66.54) Buy
Bollinger Bands (100): (64.13 - 84.07) Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.41 Sell
20-day SMA: 3.5 Sell
50-day SMA: 3.71 Sell
200-day SMA: 3.44 Sell
8-day EMA: 3.37 Sell
20-day EMA: 3.49 Sell
50-day EMA: 3.63 Sell
200-day EMA: 3.44 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.79 Sell
20-day SMA: 65.64 Buy
50-day SMA: 66.69 Sell
200-day SMA: 78.92 Sell
8-day EMA: 65.67 Buy
20-day EMA: 65.74 Sell
50-day EMA: 67.62 Sell
200-day EMA: 77.02 Sell

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):